Form 8-K - Current report:
SEC Accession No. 0001193125-25-047351
Filing Date
2025-03-05
Accepted
2025-03-05 17:18:49
Documents
13
Period of Report
2025-03-05
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d831088d8k.htm   iXBRL 8-K 27492
  Complete submission text file 0001193125-25-047351.txt   153884

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA spry-20250305.xsd EX-101.SCH 2846
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE spry-20250305_lab.xml EX-101.LAB 18736
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE spry-20250305_pre.xml EX-101.PRE 11704
15 EXTRACTED XBRL INSTANCE DOCUMENT d831088d8k_htm.xml XML 3773
Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Filer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39756 | Film No.: 25712442
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)